These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24899381)
1. The top clinical trial opportunities in therapeutic apheresis and neurology. Morgan SM; Shaz BH; Pavenski K; Meyer EK; Delaney M; Szczepiorkowski ZM J Clin Apher; 2014 Dec; 29(6):331-5. PubMed ID: 24899381 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic apheresis in neurology critical care. Natarajan N; Weinstein R J Intensive Care Med; 2005; 20(4):212-25. PubMed ID: 16061904 [TBL] [Abstract][Full Text] [Related]
3. Neurologic indications for therapeutic plasma exchange: an update. Gwathmey K; Balogun RA; Burns T J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutic Apheresis in Neurological Disorders]. Nakatsuji Y Brain Nerve; 2021 May; 73(5):425-430. PubMed ID: 34006672 [TBL] [Abstract][Full Text] [Related]
5. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption. Klingel R; Heibges A; Fassbender C Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee. Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice. Kes P; Basić-Kes V; Basić-Jukić N; Demarin V Acta Clin Croat; 2012 Mar; 51(1):137-53. PubMed ID: 22920015 [TBL] [Abstract][Full Text] [Related]
8. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis. Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327 [TBL] [Abstract][Full Text] [Related]
11. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B; Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814 [TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis. Ratcliffe N; Dunbar NM; Adamski J; Couriel D; Edelson R; Kitko CL; Levine JE; Morgan S; Schneiderman J; Sloan S; Wu Y; Szczepiorkowski ZM; Cooling L; Transfus Med Rev; 2015 Jan; 29(1):62-70. PubMed ID: 25459074 [TBL] [Abstract][Full Text] [Related]
17. The establishment of in-house neurology driven therapeutic plasma exchange infrastructure in a resource-limited public hospital in Malaysia: Adopting and integrating evidenced-based health care technology through time. Viswanathan S; Hiew FL J Clin Apher; 2019 Aug; 34(4):434-444. PubMed ID: 30829434 [TBL] [Abstract][Full Text] [Related]
18. A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. Josephson CD; Glynn SA; Kleinman SH; Blajchman MA; Transfusion; 2011 Apr; 51(4):828-41. PubMed ID: 21496044 [TBL] [Abstract][Full Text] [Related]
19. Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System. Galetta KM; Bhattacharyya S Med Clin North Am; 2019 Mar; 103(2):325-336. PubMed ID: 30704684 [TBL] [Abstract][Full Text] [Related]
20. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic. Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]